Showing results (191-200 of 767) with videos related to
Sort By:
Pageof 77
Translational Andrology and Urology|September 22, 2016
Surgery is not indicated for the treatment of premature ejaculationJames Anaissie, Faysal A Yafi, Wayne J G HellstromCurrent Urology Reports|June 27, 2002
Peyronie's disease: advances in basic science and pathophysiologyT J Bivalacqua, S K Purohit, W J HellstromCurrent Opinion in Investigational Drugs (London, England : 2000)|July 28, 2006
Udenafil, a long-acting PDE5 inhibitor for erectile dysfunctionEmad A Salem, Muammer Kendirci, Wayne J G HellstromInternational Journal of Impotence Research|September 1, 1999
Stimulation of collagen production in an in vitro model for Peyronie's diseaseS K Ahuja, S C Sikka, W J HellstromExpert Opinion on Pharmacotherapy|April 23, 2004
Vardenafil: a novel type 5 phosphodiesterase inhibitor for the treatment of erectile dysfunctionMuammer Kendirci, Trinity J Bivalacqua, Wayne J G HellstromThe World Journal of Men'S Health|September 8, 2017
Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment OptionAndrew T Gabrielson, Laith M Alzweri, Wayne Jg HellstromExpert Opinion on Biological Therapy|September 9, 2008
A review of current progress in gene and stem cell therapy for erectile dysfunctionSerap Gur, Philip J Kadowitz, Wayne J G HellstromThe Journal of Sexual Medicine|June 30, 2010
A protein tyrosine kinase inhibitor, imatinib mesylate (Gleevec), improves erectile and vascular function secondary to a reduction of hyperglycemia in diabetic ratsSerap Gur, Philip J Kadowitz, Wayne J G HellstromThe Journal of Sexual Medicine|April 5, 2013
Managing the difficult penile prosthesis patientLandon W Trost, Neil Baum, Wayne J G HellstromExpert Opinion on Investigational Drugs|May 22, 2008
Novel phosphodiesterase-5 (PDE5) inhibitors in the alleviation of erectile dysfunction due to diabetes and ageing-induced oxidative stressSerap Gur, Suresh C Sikka, Wayne J G HellstromPageof 77